Emily Bernstein | |
|---|---|
| Alma mater | State University of New York at Stony Brook |
| Scientific career | |
| Institutions | Mount Sinai College of Medicine |
| Thesis | Dicer, a novel RNase III, is required for RNA interference and development (2003) |
| Doctoral advisor | Gregory Hannon |
Emily Bernstein is a professor at Mount Sinai School of Medicine known for her research on RNA interference, epigenetics, and cancer, especially melanoma.
Bernstein received her B.S. from McGill University in 1998 and earned a Ph.D. from Stony Brook University in 2003. [1] Following her Ph.D. she was a postdoctoral researcher at Rockefeller University where she worked with David Allis. [2] In 2008 she moved to Mount Sinai School of Medicine where, as of 2022, she is a professor in the department of oncology and dermatology. [3]
Bernstein is known for her research on RNA interference, epigenetics, and cell development. Her early research examined the enzyme Dicer, its role in cell development in mice, [4] and RNA interference. [5] While a postdoctoral researcher she examined linkages between non-coding RNA and chromatin [6] [7] and DNA methylation. [8] Subsequently, she has worked on histones, [9] [10] gene silencing, [11] and tumor cell development. [12] [13] In 2022 her team discovered alterations to a gene which can lead to melanoma. [14] [15]
In 2014 Bernstein received a young investigators award from the Pershing Square Foundation. [16]